You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 28, 2024

Details for Patent: 10,342,810


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,342,810 protect, and when does it expire?

Patent 10,342,810 protects ZURZUVAE and is included in one NDA.

This patent has sixty-seven patent family members in twenty-six countries.

Summary for Patent: 10,342,810
Title:19-nor C3, 3-disubstituted C21-N-pyrazolyl steroids and methods of use thereof
Abstract:Provided herein are 19-nor C3,3-disubstituted C21-pyrazolyl steroids of Formula (I):
Inventor(s):Martinez Botella Gabriel, Harrison Boyd L., Robichaud Albert Jean, Salituro Francesco G., Beresis Richard Thomas
Assignee:Sage Therapeutics, Inc.
Application Number:US16020641
Patent Claim Types:
see list of patent claims
 

Drugs Protected by US Patent 10,342,810

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Biogen Inc ZURZUVAE zuranolone CAPSULE;ORAL 217369-001 Oct 31, 2023 RX Yes No ⤷  Try a Trial ⤷  Try a Trial METHOD OF TREATING POSTPARTUM DEPRESSION ⤷  Try a Trial
Biogen Inc ZURZUVAE zuranolone CAPSULE;ORAL 217369-002 Oct 31, 2023 RX Yes No ⤷  Try a Trial ⤷  Try a Trial METHOD OF TREATING POSTPARTUM DEPRESSION ⤷  Try a Trial
Biogen Inc ZURZUVAE zuranolone CAPSULE;ORAL 217369-003 Oct 31, 2023 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial METHOD OF TREATING POSTPARTUM DEPRESSION ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 10,342,810

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2014256229 ⤷  Try a Trial
Australia 2018278844 ⤷  Try a Trial
Australia 2020256400 ⤷  Try a Trial
Australia 2022205157 ⤷  Try a Trial
Brazil 112015026380 ⤷  Try a Trial
Canada 2909545 ⤷  Try a Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.